TG Therapeutics, Inc. (TGTX)
30.54
+0.11
(+0.36%)
USD |
NASDAQ |
Dec 10, 15:26
TG Therapeutics Total Liabilities (Quarterly): 417.81M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Karyopharm Therapeutics, Inc. | 365.49M |
| Axsome Therapeutics, Inc. | 595.52M |
| Krystal Biotech, Inc. | 102.22M |
| Arcutis Biotherapeutics, Inc. | 212.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Shareholders Equity (Quarterly) | 607.22M |
| Debt to Equity Ratio | 0.4178 |
| Current Ratio | 3.825 |
| Net Debt Paydown Yield | -0.50% |